MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- DISHMAN PHARMA - ADCOCK INGRAM (S. Africa)
DISHMAN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results
DISHMAN PHARMA Change
Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More
ADCOCK INGRAM (S. Africa)
Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
Financials
 DISHMAN PHARMA  ADCOCK INGRAM |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| DISHMAN PHARMA Mar-16 |
ADCOCK INGRAM Jun-14 |
DISHMAN PHARMA/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 374 | 372 | - | |
| Low | Rs | 129 | 268 | - | |
| Sales per share (Unadj.) | Rs | 197.8 | 110.6 | - | |
| Earnings per share (Unadj.) | Rs | 21.2 | -27.9 | - | |
| Cash flow per share (Unadj.) | Rs | 34.7 | -23.1 | - | |
| Dividends per share (Unadj.) | Rs | 2.00 | 0 | - | |
| Dividend yield (eoy) | % | 0.8 | 0 | - | |
| Book value per share (Unadj.) | Rs | 179.9 | 86.8 | - | |
| Shares outstanding (eoy) | m | 80.69 | 168.78 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 1.3 | 2.9 | 44.0% | |
| Avg P/E ratio | x | 11.9 | -11.5 | -103.3% | |
| P/CF ratio (eoy) | x | 7.2 | -13.9 | -52.3% | |
| Price / Book Value ratio | x | 1.4 | 3.7 | 37.9% | |
| Dividend payout | % | 9.4 | 0 | - | |
| Avg Mkt Cap | Rs m | 20,306 | 54,029 | 37.6% | |
| No. of employees | `000 | 0.8 | 4.3 | 19.3% | |
| Total wages/salary | Rs m | 5,355 | 3,391 | 157.9% | |
| Avg. sales/employee | Rs Th | 19,252.7 | 4,349.7 | 442.6% | |
| Avg. wages/employee | Rs Th | 6,459.5 | 789.9 | 817.8% | |
| Avg. net profit/employee | Rs Th | 2,064.1 | -1,096.0 | -188.3% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 15,961 | 18,673 | 85.5% | |
| Other income | Rs m | 265 | 131 | 203.0% | |
| Total revenues | Rs m | 16,226 | 18,804 | 86.3% | |
| Gross profit | Rs m | 4,103 | -3,236 | -126.8% | |
| Depreciation | Rs m | 1,091 | 806 | 135.3% | |
| Interest | Rs m | 944 | 506 | 186.7% | |
| Profit before tax | Rs m | 2,334 | -4,417 | -52.8% | |
| Minority Interest | Rs m | 0 | -12 | 0.0% | |
| Prior Period Items | Rs m | 1 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Tax | Rs m | 624 | 276 | 225.9% | |
| Profit after tax | Rs m | 1,711 | -4,705 | -36.4% | |
| Gross profit margin | % | 25.7 | -17.3 | -148.4% | |
| Effective tax rate | % | 26.7 | -6.2 | -427.7% | |
| Net profit margin | % | 10.7 | -25.2 | -42.5% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 11,018 | 13,677 | 80.6% | |
| Current liabilities | Rs m | 9,517 | 7,695 | 123.7% | |
| Net working cap to sales | % | 9.4 | 32.0 | 29.4% | |
| Current ratio | x | 1.2 | 1.8 | 65.1% | |
| Inventory Days | Days | 110 | 111 | 99.6% | |
| Debtors Days | Days | 35 | 124 | 28.1% | |
| Net fixed assets | Rs m | 16,304 | 7,972 | 204.5% | |
| Share capital | Rs m | 161 | 87 | 186.2% | |
| Net worth | Rs m | 14,516 | 14,656 | 99.0% | |
| Long term debt | Rs m | 4,189 | 5,151 | 81.3% | |
| Total assets | Rs m | 29,805 | 27,687 | 107.6% | |
| Interest coverage | x | 3.5 | -7.7 | -44.9% | |
| Debt to equity ratio | x | 0.3 | 0.4 | 82.1% | |
| Sales to assets ratio | x | 0.5 | 0.7 | 79.4% | |
| Return on assets | % | 8.9 | -15.2 | -58.7% | |
| Return on equity | % | 11.8 | -32.1 | -36.7% | |
| Return on capital | % | 17.5 | -19.8 | -88.5% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 2,786 | 1,594 | 174.8% | |
| From Investments | Rs m | -1,529 | -489 | 312.4% | |
| From Financial Activity | Rs m | -941 | 4,674 | -20.1% | |
| Net Cashflow | Rs m | 316 | 5,779 | 5.5% | |
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.13 Rs / ZAR
Compare DISHMAN PHARMA With: ACTAVIS (US) MYLAN (US) TEVA PHARMA (Israel)
Compare DISHMAN PHARMA With: UNICHEM LAB PFIZER ABBOTT INDIA STERLING BIOTECH AJANTA PHARMA
Today's Market
Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)
Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.
Related Views On News
Most Popular
A Critical Update on the Market (Fast Profits Daily)
Mar 30, 2021In this video, I'll tell you why I am recommending caution in the market at this time.
My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)
Mar 31, 2021A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
My Stock Trading Strategy (Fast Profits Daily)
Mar 31, 2021In this video I'll show you exactly how I go about picking stocks for trading.
What You Need to Find Hundred Baggers (Profit Hunter)
Mar 30, 2021100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.
More
